UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunological and classical subtypes of oral premalignant lesions

Oncoimmunology, 2018-12, Vol.7 (12), p.e1496880-e1496880

2018

Volltextzugriff (PDF)

Oxidative metabolism of linoleic acid modulates PPAR-beta delta suppression of PPAR-gamma activity

Oncogene, 2006-02, Vol.25 (8), p.1225-1241

2006

Volltextzugriff (PDF)

The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival

Annals of oncology, 2012-01, Vol.23 (1), p.78-85

2012

Volltextzugriff (PDF)

Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2001-04, Vol.93 (8), p.605-618

2001

Volltextzugriff (PDF)

Clonal Genetic alterations in the lungs of current and former smokers

JNCI : Journal of the National Cancer Institute, 1997-06, Vol.89 (12), p.857-862

1997

Volltextzugriff (PDF)

Cyclooxygenase-2 Overexpression Is a Marker of Poor Prognosis in Stage I Non-Small Cell Lung Cancer

Clinical cancer research, 2001-04, Vol.7 (4), p.861-867

2001

Volltextzugriff (PDF)

Molecular Markers of the Risk of Oral Cancer

The New England journal of medicine, 2001-04, Vol.344 (17), p.1323-1326

2001

Volltextzugriff (PDF)

Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma

Journal of clinical oncology, 1998-06, Vol.16 (6), p.2221-2232

1998

Volltextzugriff (PDF)

Selenium Effects on Prostate Cell Growth

Cancer epidemiology, biomarkers & prevention, 2000-11, Vol.9 (11), p.1171

2000

Volltextzugriff (PDF)

Cancer Chemoprevention: Progress and Promise

JNCI : Journal of the National Cancer Institute, 1998-10, Vol.90 (20), p.1514-1528

1998

Volltextzugriff (PDF)

15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells

Cancer research (Chicago, Ill.), 2000-12, Vol.60 (24), p.6846-6850

2000

Volltextzugriff (PDF)

p53 Expression: Predicting Recurrence and Second Primary Tumors in Head and Neck Squamous Cell Carcinoma

JNCI : Journal of the National Cancer Institute, 1996-04, Vol.88 (8), p.519-529

1996

Volltextzugriff (PDF)

Tamoxifen Prevention of Breast Cancer: an Instance of the Fingerpost

JNCI : Journal of the National Cancer Institute, 1999-11, Vol.91 (21), p.1809-1819

1999

Volltextzugriff (PDF)

Cancer chemoprevention

Journal of clinical oncology, 1994-04, Vol.12 (4), p.851-873

1994

Volltextzugriff (PDF)

Lipoxygenase modulation to reverse carcinogenesis

Cancer research (Chicago, Ill.), 2001-09, Vol.61 (17), p.6307-6312

2001

Volltextzugriff (PDF)

Finasteride and High-Grade Prostate Cancer in the Prostate Cancer Prevention Trial

JNCI : Journal of the National Cancer Institute, 2007-09, Vol.99 (18), p.1375-1383

2007

Volltextzugriff (PDF)

Non-steroidal anti-inflammatory drugs and the risk of oral cancer : a nested case-control study

The Lancet (British edition), 2005-10, Vol.366 (9494), p.1359-1366

2005

Volltextzugriff (PDF)

Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-α in normal and malignant prostate cells

Cancer research (Chicago, Ill.), 2001-03, Vol.61 (6), p.2720-2726

2001

Volltextzugriff (PDF)

Molecular Epidemiology and Retinoid Chemoprevention of Head and Neck Cancer

JNCI : Journal of the National Cancer Institute, 1997-02, Vol.89 (3), p.199-211

1997

Volltextzugriff (PDF)

Chemoprevention of breast cancer

Breast cancer research and treatment, 2000-07, Vol.62 (1), p.1-17

2000

Volltextzugriff (PDF)

Phenotype and Genotype of Advanced Premalignant Head and Neck Lesions After Chemopreventive Therapy

JNCI : Journal of the National Cancer Institute, 1998-10, Vol.90 (20), p.1545-1551

1998

Volltextzugriff (PDF)

Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer

Journal of clinical oncology, 1997-01, Vol.15 (1), p.310-316

1997

Volltextzugriff (PDF)

Combined Interferon-Alfa, 13-cis-Retinoic Acid, and Alpha-Tocopherol in Locally Advanced Head and Neck Squamous Cell Carcinoma: Novel Bioadjuvant Phase II Trial

Journal of clinical oncology, 2001-06, Vol.19 (12), p.3010-3017

2001

Volltextzugriff (PDF)

Mediation of N-(4-hydroxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms

Cancer research (Chicago, Ill.), 1999-05, Vol.59 (10), p.2493-2498

1999

Volltextzugriff (PDF)

Suppression of Retinoic Acid Receptor–β in Premalignant Oral Lesions and Its Up-Regulation by Isotretinoin

The New England journal of medicine, 1995-05, Vol.332 (21), p.1405-1411

1995

Volltextzugriff (PDF)

1 – 25 von 1.938

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.754)
Mit Volltextzugriff
(1.576)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Immunological and classical subtypes of oral premalignant lesions

Oxidative metabolism of linoleic acid modulates PPAR-beta delta suppression of PPAR-gamma activity

The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival

Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer

Clonal Genetic alterations in the lungs of current and former smokers

Cyclooxygenase-2 Overexpression Is a Marker of Poor Prognosis in Stage I Non-Small Cell Lung Cancer

Molecular Markers of the Risk of Oral Cancer

Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma

Selenium Effects on Prostate Cell Growth

Cancer Chemoprevention: Progress and Promise

15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells

p53 Expression: Predicting Recurrence and Second Primary Tumors in Head and Neck Squamous Cell Carcinoma

Tamoxifen Prevention of Breast Cancer: an Instance of the Fingerpost

Cancer chemoprevention

Lipoxygenase modulation to reverse carcinogenesis

Finasteride and High-Grade Prostate Cancer in the Prostate Cancer Prevention Trial

Non-steroidal anti-inflammatory drugs and the risk of oral cancer : a nested case-control study

Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-α in normal and malignant prostate cells

Molecular Epidemiology and Retinoid Chemoprevention of Head and Neck Cancer

Chemoprevention of breast cancer

Phenotype and Genotype of Advanced Premalignant Head and Neck Lesions After Chemopreventive Therapy

Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer

Combined Interferon-Alfa, 13-cis-Retinoic Acid, and Alpha-Tocopherol in Locally Advanced Head and Neck Squamous Cell Carcinoma: Novel Bioadjuvant Phase II Trial

Mediation of N-(4-hydroxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms

Suppression of Retinoic Acid Receptor–β in Premalignant Oral Lesions and Its Up-Regulation by Isotretinoin

Aktive Filter

Suchergebnisse filtern